In turn, the suppression of cell cycle in malignant cells upon anti-PD1 treatment resulted in a reduction of epithelial (EPCAM+) cells in the tumors, supporting the tumor size shrinkage observed on the anti-PD1 treated mice (Supplementary Fig. 6n). The gene discussed is EPCAM; the disease is neoplasm.